Eyes Pharma Partner Elixirgen Wins 'Bayer Corlab Connect Seoul'
Predicted impact: Medium· Actual: −9.3% vs sector, volume 1.3× normal (5 trading days)
Amended convertible bond issue decision; dilution size not stated in data.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.